Valuation (86%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 16.15 | N/A |
| PEG Ratio (TTM) | 0.21 | N/A |
| P/S Ratio (TTM) | 1.15 | N/A |
| P/B Ratio (TTM) | 1.45 | N/A |
| P/FCF Ratio (TTM) | 13.82 | N/A |
| Price to 5YR AVG Earnings Ratio | 21.01 | N/A |
| Price to 5YR AVG FCF Ratio | 18.66 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.50% | N/A |
| ROE (TTM) | 9.15% | N/A |
| Net Profit Margin (TTM) | 7.19% | N/A |
| ROIC 5YR AVG | 7.21% | N/A |
Growth (33%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 101.35% | 4.85% | -7.94% |
| Revenue | -1.04% | 1.55% | 4.22% |
| Net Income | 100.91% | 3.16% | -9.47% |
| Cash Flow | -10.32% | 4.87% | 16.22% |
Health (74%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.46 | N/A |
| Quick Ratio (TTM) | 1.72 | N/A |
| D/E Ratio (TTM) | 0.58 | N/A |
| Interest Coverage (TTM) | 4.62 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 3.03 | N/A |
| LTL to 5YR AVG FCF | 7.22 | N/A |
| Shares Outstanding Growth 5YR AVG | -1.64% | N/A |